Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment

Overview

Twenty-five women will be followed through their breast cancer treatment. The women will be asked to provide their opinions and desires for lifestyle intervention at different times throughout treatment. In addition, basic clinical data will be collected . The primary goal of this pilot study is to investigate the physical and behavioral changes that occur in patients receiving treatment for breast cancer.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: September 11, 2018

Detailed Description

In this cross sectional, longitudinal, observational study, 25 women will be followed through their treatment for stage I-III breast cancer. The women will be asked to provide their opinions and desires for lifestyle intervention at four timepoints throughout treatment. In addition to qualitative data, basic clinical data will be collected (anthropometrics, vital signs, dietary intake, and physical activity). The primary goal of this pilot study is to investigate the anthropometric and behavioral changes that occur in patients undergoing adjuvant chemotherapy for breast cancer. Aim 1: To better understand patients' attitudes toward and perceived barriers to nutrition and physical activity interventions during neoplastic treatment. Hypothesis: Patients' reported attitudes, motivation, and perceived barriers will change throughout treatment. Aim 2: To measure the physical and metabolic changes that occur throughout neoplastic treatment for breast cancer. Hypothesis: Over 50% of the participants will gain body weight during treatment and metabolic parameters will trend with body weight change.

Clinical Trial Outcome Measures

Primary Measures

  • Perceived attitudes towards lifestyle interventions
    • Time Frame: 9 months
    • Qualitative data collected via semi-structured interview

Secondary Measures

  • Diet
    • Time Frame: 9 months
    • 24 hour recall (ASA24) to assess food intake changes throughout treatment
  • Physical Activity
    • Time Frame: 9 months
    • Wrist worn Actigraph accelerometer to assess activity changes throughout treatment
  • Body Weight
    • Time Frame: 9 months
    • Body weight change throughout treatment

Participating in This Clinical Trial

Inclusion Criteria

  • Female – ≥18 years of age – Diagnosed with stage I, II or III breast cancer with plans to undergo endocrine and/or chemotherapy treatment (radiation in combination with one or more of these therapies is acceptable) – Willing to complete up to 4 clinic visits Exclusion Criteria:

  • Have received neoadjuvant therapy for current diagnosis – Currently receiving adjuvant chemotherapy or other adjuvant therapy that was initiated prior to study enrollment – History of cancer and neoplastic treatment

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Pennington Biomedical Research Center
  • Provider of Information About this Clinical Study
    • Principal Investigator: Anne Gilmore, Assistant Professor – Pennington Biomedical Research Center
  • Overall Official(s)
    • Anne Gilmore, PhD, Principal Investigator, Pennington Biomedical Research Center

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.